Skip to main navigation Skip to search Skip to main content

Recommendations to enhance pediatric cardiovascular drug development: Report of a multi-stakeholder think tank

  • Rachel D. Torok
  • , Jennifer S. Li
  • , Prince J. Kannankeril
  • , Andrew M. Atz
  • , Raafat Bishai
  • , Ellen Bolotin
  • , Stefanie Breitenstein
  • , Cathy Chen
  • , Thomas Diacovo
  • , Timothy Feltes
  • , Patricia Furlong
  • , Michael Hanna
  • , Eric M. Graham
  • , Daphne Hsu
  • , D. Dunbar Ivy
  • , Dianne Murphy
  • , Lisa A. Kammerman
  • , Gregory Kearns
  • , John Lawrence
  • , Brigitte Lebeaut
  • Danshi Li, Christoph Male, Brian McCrindle, Pierre Mugnier, Jane W. Newburger, Gail D. Pearson, Vasum Peiris, Lisa Percival, Miriam Pina, Ronald Portman, Robert Shaddy, Norman L. Stockbridge, Robert Temple, Kevin D. Hill
  • Duke University
  • Vanderbilt University
  • Medical University of South Carolina
  • AstraZeneca
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Nationwide Children’s Hospital
  • Parent Project Muscular Dystrophy
  • Bristol-Myers Squibb
  • Albert Einstein College of Medicine
  • The Children's Hospital, Aurora
  • United States Food and Drug Administration
  • Arkansas Children's Hospital
  • Medical University of Vienna
  • University of Toronto
  • Boston Children's Hospital
  • National Institutes of Health
  • Johnson & Johnson
  • Novartis
  • Children's Hospital Los Angeles

Research output: Contribution to journalArticlepeer-review

28 Scopus citations
Original languageEnglish
Article numbere007283
JournalJournal of the American Heart Association
Volume7
Issue number4
DOIs
StatePublished - Feb 1 2018

Fingerprint

Dive into the research topics of 'Recommendations to enhance pediatric cardiovascular drug development: Report of a multi-stakeholder think tank'. Together they form a unique fingerprint.

Cite this